|
|
542 Flynn Road
Camarillo, CA 93012 USA
phone:(805) 987-0086
fax:(805) 987-3385
|
|
| Symbol |
BIOI |
| Exchange |
|
| Founded |
1989 |
| Employees |
|
|
|
| www.biosource.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Functional proteomics and advanced drug discovery with a focus in in immunology. |
|
| Management |
| Terrance J. Bieker, President and Chief Executive Officer; Alan Edrick, Executive Vice President and Chief Financial Officer; Kevin J. Reagan, Ph.D., Executive Vice President of Technical Operations; Jozef Vangenechten, Ph.D Executive Vice |
| |
|
|
|
|
|
|
|
| Keywords |
| drug therapies, biomedical, research, diagnostic |
|
|
|
| Description |
|
Biosource International, Inc. is providing solutions in the areas of functional proteomics and advanced drug discovery through the development, manufacturing, marketing, and distribution of unique biologically active reagent systems which facilitate, enable, and accelerate pharmaceutical development as well as biomedical research. |
|
| Products / Services |
Immunology, Signal Transduction, Multiplex Reagents, Sera, Media and Buffers
|
|
|
| Strategy |
Biosource International already has agreements with many individual scientists, universities, research institutes and biotechnology companies covering the commercialization of monoclonal and polyclonal antibodies, recombinant proteins, vectors, ELISA reagents, antibody labels etc. These agreements include the outright purchase of reagents as well as nonexclusive and exclusive licenses. Licenses generally involve an up-front payment plus royalty on the sales of products containing the licensed reagent. Most institutions have an Office of Technology Transfer that helps with the negotiations and finalizing the written agreement. Besides the financial benefits of the program, researchers are released from the administrative burden of providing samples and technical information to other scientists. In addition, Biosource's quality control department insures lot to lot reproducibility of transferred reagents thus eliminating a variable in the interpretation of data.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
